BLUE
STOCK SCORE
BLUE
STOCK SCORE
Target 1Y
Login to View
Target 6M
Login to View
Valuation
Login to View
Max Portfolio %
Login to View
Last 7 days
-0.6%
Last 30 days
-1.8%
BLUE RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Target 1Y
Login to View
Target 6M
Login to View
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 4.0M | 9.4M | 21.7M | 0 |
| 2022 | 4.7M | 6.1M | 5.1M | 3.6M |
| 2021 | 189.0M | 127.2M | 65.4M | 3.7M |
| 2020 | 54.1M | 239.7M | 250.0M | 250.7M |
| 2019 | 51.1M | 56.5M | 53.9M | 44.7M |
| 2018 | 44.6M | 35.7M | 39.5M | 54.6M |
| 2017 | 11.5M | 26.7M | 32.8M | 35.4M |
| 2016 | 9.2M | 5.8M | 6.1M | 6.2M |
| 2015 | 25.4M | 24.0M | 19.0M | 14.1M |
| 2014 | 25.4M | 25.4M | 25.4M | 25.4M |
| 2013 | 1.4M | 7.6M | 13.9M | 20.2M |
| 2012 | 0 | 274.7K | 307.3K | 340.0K |
| 2011 | 0 | 0 | 0 | 242.0K |
| CEO | Mr. Andrew Obenshain |
|---|---|
| WEBSITE | bluebirdbio.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 323 |